GSK sells $3.4 billion Hindustan Unilever stake in largest India block trade
Published
GlaxoSmithKline has sold its stake in Unilever's Indian business for $3.4 billion, marking India's largest block trade, which will help the British company in its goal of reinvigorating its drug development pipeline.
Full Article